Evidence map›Paper›PMID 34468722›Full record

ArticleInternational journal of epidemiology2022

Coffee and tea consumption and mortality from all causes, cardiovascular disease and cancer: a pooled analysis of prospective studies from the Asia Cohort Consortium.

Sangah Shin, Jung Eun Lee, Erikka Loftfield, Xiao-Ou Shu, Sarah Krull Abe, Md Shafiur Rahman, Eiko Saito, Md Rashedul Islam, Shoichiro Tsugane, Norie Sawada and 28 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 18 institutions in 6 countries.

Sangah ShinDepartment of Food and Nutrition, Chung-Ang University, Gyeonggi-do, Korea.
Jung Eun LeeDepartment of Food and Nutrition, Seoul National University, Seoul, Korea.ORCID 0000-0003-1141-878X
Erikka LoftfieldMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-0711-8314
Sarah Krull AbeDivision of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Md Shafiur RahmanDivision of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Eiko SaitoDivision of Cancer Statistics Integration, Center for Cancer Control & Information Services, National Cancer Center, Tokyo, Japan.
Md Rashedul IslamDivision of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Shoichiro TsuganeEpidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Norie SawadaEpidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.ORCID 0000-0002-9936-1476
Ichiro TsujiDepartment of Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Seiki KanemuraDepartment of Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yumi SugawaraDepartment of Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yasutake TomataDepartment of Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Atsuko SadakaneDepartment of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
Kotaro OzasaDepartment of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
Isao OzeDivision of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0002-0762-1147
Hidemi ItoDivision of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
Myung-Hee ShinDepartment of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Gyeonggi-do, Korea.
Yoon-Ok AhnDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Sue K ParkDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-5002-9707
Aesun ShinDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Yong-Bing XiangState Key Laboratory of Oncogene and Related Genes and Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Hui CaiDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Woon-Puay KohHealthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore.
Jian-Min YuanDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Keun-Young YooThe Veterans Health Service Medical Center, Seoul, Korea.
Kee Seng ChiaSaw Swee Hock School of Public Health, National University of Singapore, Republic of Singapore.
Paolo BoffettaStony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.
Habibul AhsanDepartment of Public Health Sciences, University of Chicago, Chicago, IL, USA.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0003-1226-070X
Manami InoueDivision of Prevention, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.ORCID 0000-0003-1276-2398
Daehee KangDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
John D PotterResearch Centre for Hauora and Health, Massey University, Wellington, New Zealand.
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0003-1761-6314
You-Lin QiaoCenter for Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Rashmi SinhaMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Seoul National University · KRNational Center for Global Health and Medicine · JPTohoku University · JPAichi Cancer Center · JPVanderbilt University Medical Center · USNational Cancer Institute · USNational University of Singapore · SGRadiation Effects Research Foundation · JPChicago Department of Public Health · USChinese Academy of Medical Sciences & Peking Union Medical College · CNChung-Ang University · KRMassey University · NZNational Institutes of Health · USRenji Hospital · CNStony Brook University · USSungkyunkwan University · KRUniversity of Pittsburgh · USVeterans Health Service Medical Center · KR

Funding

Prospective studies of cancer etiology and prevention in Shanghai and SingaporeR01CA144034 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2010 to 2014
$7.0M
Shanghai Womens Health StudyUM1CA182910 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2014 to 2018
$5.9M
THE SINGAPORE COHORT STUDY OF DIET AND CANCERR01CA080205 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YUAN, JIAN-MIN · 1999 to 2009
$5.3M
Shanghai Men's Health StudyUM1CA173640 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHU, XIAO-OU · 2013 to 2017
$4.9M
Cancer Risk Reduction and Diet: A Cohort Study of WomenR37CA070867 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2009 to 2013
$4.7M
Cancer epidemiology cohorts in Shanghai and Singapore UM1CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2014 to 2018
$4.3M
Etiologic Studies of Diet and CancerZIACP010127 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$3.5M
NCI NIH HHS R01 CA080205NCI NIH HHS R01 CA144034NCI NIH HHS R37 CA070867NCI NIH HHS UM1 CA173640NCI NIH HHS UM1 CA182876NCI NIH HHS UM1 CA182910
6 · The paper itself

Abstract

backgroundAccumulating evidence suggests that consuming coffee may lower the risk of death, but evidence regarding tea consumption in Asians is limited. We examined the association between coffee and tea consumption and mortality in Asian populations.

methodsWe used data from 12 prospective cohort studies including 248 050 men and 280 454 women from the Asia Cohort Consortium conducted in China, Japan, Korea and Singapore. We estimated the study-specific association of coffee, green tea and black tea consumption with mortality using Cox proportional-hazards regression models and the pooled study-specific hazard ratios (HRs) using a random-effects model.

resultsIn total, 94 744 deaths were identified during the follow-up, which ranged from an average of 6.5 to 22.7 years. Compared with coffee non-drinkers, men and women who drank at least five cups of coffee per day had a 24% [95% confidence interval (CI) 17%, 29%] and a 28% (95% CI 19%, 37%) lower risk of all-cause mortality, respectively. Similarly, we found inverse associations for coffee consumption with cardiovascular disease (CVD)-specific and cancer-specific mortality among both men and women. Green tea consumption was associated with lower risk of mortality from all causes, CVD and other causes but not from cancer. The association of drinking green tea with CVD-specific mortality was particularly strong, with HRs (95% CIs) of 0.79 (0.68, 0.91) for men and 0.78 (0.68, 0.90) for women who drank at least five cups per day of green tea compared with non-drinkers. The association between black tea consumption and mortality was weak, with no clear trends noted across the categories of consumption.

conclusionsIn Asian populations, coffee consumption is associated with a lower risk of death overall and with lower risks of death from CVD and cancer. Green tea consumption is associated with lower risks of death from all causes and CVD.

Indexed as

Cardiovascular DiseasesNeoplasmsAsiaCoffeeCohort StudiesFemaleHumansMaleProportional Hazards ModelsProspective StudiesRisk FactorsSurveys and QuestionnairesTeaCoffeeTeaAsianCoffeemortalitytea

Identifiers

PMID34468722
PMCPMC9308394
OpenAlexW3198066757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.